Bridging Intestinal Failure With Teduglutide - a Case Report

Completed

• Conditions: Short Bowel Syndrome

• Registration Number: NCT04916665
• Lead Sponsor: Medical University of Vienna

Brief Summary

In this case report the investigators present a novel strategy for using teduglutide as a bridging therapy to intestinal reconstruction.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-01-01
• Primary Completion: 2019-12-31
• Study Completion: 2019-12-31
• Study First Submitted: 2021-05-30
• Status Verified: 2021-06
• Study First Submitted QC: 2021-06-03
• Last Update Submitted: 2021-06-03
• Study First Posted: 2021-06-07
• Last Update Posted: 2021-06-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 1

Inclusion Criteria

short bowel syndrome

Exclusion Criteria

• <18 years

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
enteral autonomy (complete discontinuation of parenteral support)	6 months	observe if enteral autonomy may be achieved before reconstruction

Trial Locations

Locations (1)

Medical University of Vienna; 🇦🇹 Vienna, Austria